LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC)

被引：4
|
作者：
El-Khoueiry, Anthony B.
Llovet, Josep M.
Vogel, Arndt
Madoff, David C.
Finn, Richard S.
Ogasawara, Sadahisa
Ren, Zhenggang
Mody, Kalgi
Li, Jerry J.
Siegel, Abby B.
Dubrovsky, Leonid
Kudo, Masatoshi
机构：
[1] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA
[2] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA
[3] Univ Barcelona, Hosp Clin Barcelona, IDIBAPS, Catalonia, Spain
[4] Inst Catalana dEstudis Avancats ICREA, Barcelona, Spain
[5] Hannover Med Sch, Hannover, Germany
[6] Smilow Canc Hosp, Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[7] Smilow Canc Hosp, Yale New Haven Hlth, New Haven, CT USA
[8] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[9] Chiba Univ, Grad Sch Med, Chiba, Japan
[10] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[11] NJ Merck Co Inc, Woodcliff Lake, Kenilworth, NJ USA
[12] Kindai Univ, Sch Med, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.TPS494
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS494
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Kanai, Fumihiko
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    ONCOLOGY, 2014, 87 (06) : 330 - 341
  • [32] LIVER RESECTION VERSUS TRANSARTERIAL CHEMOEMBOLIZATION FOR THE TREATMENT OF INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Zhu, Wanjie
    Chen, Shuling
    Jin, Huilin
    GUT, 2019, 68 : A128 - A128
  • [33] Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
    Chen, Shuling
    Peng, Zhenwei
    Zhang, Yaojun
    Chen, Minshan
    Li, Jiaping
    Guo, Rongping
    Li, Jiali
    Li, Bin
    Mei, Jie
    Feng, Shiting
    Kuang, Ming
    RADIOLOGY, 2021, 298 (03) : 680 - 692
  • [34] Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis
    Zhang, Leida
    Hu, Peng
    Chen, Xi
    Bie, Ping
    PLOS ONE, 2014, 9 (06):
  • [35] Transarterial chemoembolization (TACE) plus lenvatinib versus TACE plus sorafenib for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A prospective randomized study
    Ding, X.
    Sun, W.
    Chen, J.
    Li, W.
    Shen, Y.
    Guo, X.
    Teng, Y.
    Liu, X.
    Li, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S1306 - S1306
  • [36] Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort study
    Lang, Mengran
    Gan, Leijuan
    Ren, Shaohua
    Han, Ruyu
    Ma, Xiaochen
    Li, Guangtao
    Li, Huikai
    Zhang, Ti
    Wu, Qiang
    Cui, Yunlong
    Zhang, Wei
    Fang, Feng
    Li, Qiang
    Lu, Wei
    Song, Tianqiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2540 - +
  • [37] Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization
    Ashour, Reham
    Rewisha, Eman
    Rady, Mohamed A. K. L.
    Elkhadry, Sally Waheed
    Abdelhalim, Heba
    Atef, Mohamed
    BMC CANCER, 2024, 24 (01)
  • [38] Hepatic Resection Versus Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Cohort Study
    Lu, Linbin
    Zheng, Peichan
    Wu, Zhixian
    Chen, Xiong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
    Sansonno, Domenico
    Lauletta, Gianfranco
    Russi, Sabino
    Conteduca, Vincenza
    Sansonno, Loredana
    Dammacco, Franco
    ONCOLOGIST, 2012, 17 (03): : 359 - 366
  • [40] Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012) : a multicentre, randomised, double-blind, phase 3 study
    Kudo, Masatoshi
    Ren, Zhenggang
    Guo, Yabing
    Han, Guohong
    Lin, Hailan
    Zheng, Jinfang
    Ogasawara, Sadahisa
    Kim, Ji Hoon
    Zhao, Haitao
    Li, Chuan
    Madoff, David C.
    Ghobrial, R. Mark
    Kawaoka, Tomokazu
    Ikeda, Masafumi
    Gerolami, Rene
    Kumada, Hiromitsu
    El-Khoueiry, Anthony B.
    Vogel, Arndt
    Peng, Xiang
    Mody, Kalgi
    Dutcus, Corina
    Dubrovsky, Leonid
    Siegel, Abby B.
    Finn, Richard S.
    Llovet, Josep M.
    LANCET, 2025, 405 (10474): : 203 - 215
12345